Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluating Duloxetine's Analgesic Effectiveness in Chronic Pelvic Pain
NCT01451606Phase 4Terminated
- Sponsor
- University of Maryland, Baltimore
- Start
- Jul 2011
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic pelvic pain (CPP) comparing Placebo pill with Duloxetine (2 arms). Primary endpoint: Change in Rating of Spontaneous Pelvic Pain at 8 weeks. Started Jul 2011; status: terminated.
02
Drugs
duloxetine
03
Conditions
chronic pelvic pain (CPP)
Beyond the preview
Go deeper on NCT01451606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01451606.